According to a new market research report launched by Inkwood Research, the Global Sepsis DiagnosticsMarket is evolving at 8.06% of CAGR between 2021 and 2028 and is projected to generate $902.8 million by 2028.
Browse 59 market data Tables and 48 Figures spread over 220 Pages, along with in-depth analysis on Global Sepsis Diagnostics Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type & by Geography.
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market by assessing major geographies, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.
Global Sepsis Diagnostics Market Scenario
There are approximately 27 million patients diagnosed with sepsis each year. A study from NCBI stated that the number of sepsis-related deaths is increasing, making it a leading cause of fatality in many countries. Sepsis refers to the body’s response to pathogenic microorganisms in the blood. The rising incidences have surged the need for advanced, efficient, and rapid diagnostic techniques, which is a key driver to the global market.
Moreover, surging government initiatives for research, the spread of infectious diseases like COVID-19, and complications due to HAIS, are other factors contributing to the market’s growth. Several international players like Siemens Healthineers and Roche focus on creating initiatives that promote awareness and develop novel technologies in the segment. However, high costs and complications associated with the reimbursement policies are key concerns faced by players, thereby influencing the overall growth.
Request Free Sample Report for Global Sepsis Diagnostics Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type & by Geography: https://www.inkwoodresearch.com/reports/sepsis-diagnostics-market#request-free-sample
Market by Technology
- Molecular Diagnostics
- Other Technologies
Market by Diagnostic Method
- Automated Diagnostics
- Conventional Diagnostics
Market by Product
- Assay Kits & Reagents
- Blood Culture Media
Market by Pathogen
- Fungal Sepsis
- Gram-Positive and Gram-Negative Bacterial Sepsis
- Other Pathogens
Market by Testing Type
- Point-Of-Care Testing
- Laboratory Testing
– The report provides a detailed analysis of the current and future market trends to identify the investment opportunities
– Market forecasts till 2028, using estimated market values as the base numbers
– Key market trends across the business segments, regions, and countries
– Key developments and strategies observed in the market
– Market dynamics such as drivers, restraints, opportunities, and other trends
– In-depth company profiles of key players and upcoming prominent players
– Growth prospects among the emerging nations through 2028
- ABBOTT LABORATORIES
- BECTON, DICKINSON AND COMPANY
- BIOMERIEUX SA
- RESPONSE BIOMEDICAL CORPORATION
- F. HOFFMANN-LA ROCHE
- EKF DIAGNOSTICS
- IMMUNEXPRESS INC
- BRUKER CORPORATION
- THERMO FISHER SCIENTIFIC INC
- LUMINEX CORPORATION
- T2 BIOSYSTEMS INC
GLOBAL PRECISION MEDICINE MARKET – Global precision medicine market is projected to register a CAGR of 9.86% during the forecasting years.
GLOBAL ANESTHESIA MACHINERY MARKET – Global anesthesia machinery market is growing at a CAGR of 6.72% between 2021 and 2028.
GLOBAL PULMONARY DRUG DELIVERY MARKET – Global pulmonary drug delivery market is propelling at a CAGR of 5.06%.